Development of Adenovirus-Based Covid-19 Vaccine Candidate in Indonesia
-
Published:2023-04-19
Issue:2
Volume:66
Page:222-232
-
ISSN:1073-6085
-
Container-title:Molecular Biotechnology
-
language:en
-
Short-container-title:Mol Biotechnol
Author:
Artarini AnitaORCID, Hadianti Tia, Giri-Rachman Ernawati ArifinORCID, Tan Marselina IrasoniaORCID, Safitri Intan A., Hidayat Nurhamidah A., Retnoningrum Debbie S.ORCID, Natalia DessyORCID
Funder
Yayasan Solidarity Forever.
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference38 articles.
1. Statistik, B. P. (2021). 2020 Population Census. Berita Resmi Statistik No. 7/01/Th. XXIV. Retrieved April 26, 2022, from https://www.bps.go.id/pressrelease/2021/01/21/1854/hasil-sensus-penduduk-2020.html 2. Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Collins, A. M., Colin-Jones, R., Cutland, C. L., Darton, T. C., Dheda, K., & Zuidewind, P. (2021). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 397(10269), 99–111. https://doi.org/10.1016/S0140-6736(20)32661-1 3. Sadoff, J., Gray, G., Vandebosch, A., Cárdenas, V., Shukarev, G., Grinsztejn, B., Goepfert, P. A., Truyers, C., Fennema, H., Spiessens, B., Offergeld, K., Scheper, G., Taylor, K. L., Robb, M. L., Treanor, J., Barouch, D. H., Stoddard, J., Ryser, M. F., Marovich, M. A., ENSEMBLE Study Group. (2021). Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. The New England journal of medicine. https://doi.org/10.1056/NEJMoa2101544 4. Halperin, S. A., Ye, L., MacKinnon-Cameron, D., Smith, B., Cahn, P. E., Ruiz-Palacios, G. M., Ikram, A., Lanas, F., Lourdes Guerrero, M., Muñoz Navarro, S. R., Sued, O., Lioznov, D. A., Dzutseva, V., Parveen, G., Zhu, F., Leppan, L., Langley, J. M., Barreto, L., Gou, J., & Zubkova, T. (2022). Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-cont. The Lancet, 399(10321), 237–248. https://doi.org/10.1016/S0140-6736(21)02753-7 5. Logunov, D. Y., Dolzhikova, I. V., Shcheblyakov, D. V., Tukhvatulin, A. I., Zubkova, O. V., Dzharullaeva, A. S., Kovyrshina, A. V., Lubenets, N. L., Grousova, D. M., Erokhova, A. S., Botikov, A. G., Izhaeva, F. M., Popova, O., Ozharovskaya, T. A., Esmagambetov, I. B., Favorskaya, I. A., Zrelkin, D. I., Voronina, D. V., & Gintsburg, A. L. (2021). Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: An interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet, 397(10275), 671–681. https://doi.org/10.1016/S0140-6736(21)00234-8
|
|